The discovery offers insight into why shift workers experience metabolic disruption, which could lead to new therapies for ...

Regenerative medicine is rapidly developing and is already being applied in most countries worldwide. However, the best ...

Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and ...

Researchers from Adipo Therapeutics LLC presented data from preclinical studies that aimed to assess the γ-secretase inhibitor ADPO-002 (dibenzazepine) for the treatment of obesity.

This study demonstrates that global or adipose tissue-specific knockout of CIDEC/FSP27 significantly reduces AAA incidence ...

The increases in PGC1⍺, PRDM16 and Uncoupling Protein 1 (UCP1) in these studies support ADPO-002's mechanism of action for mitochondrial biogenesis, activation and browning of human white adipose ...

Recent research reveals that the immune system interacts with the body's internal clock, influencing both fat storage and temperature regulation. These insights carry substantial implications for ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...

Further expands already formidable intellectual property estate the Company has been building for its novel ThermoStem® technology platform ...

BioRestorative Therapies (BRTX) announces that the Israel Patent Office has issued a Notice of Allowance for a new patent application covering ...